Victoza Liraglutide Injection, Grade Standard: Medicine Grade
₹ 4,500/ PieceGet Latest Price
Brand | Victoza |
Usage/Application | Hospital, Personal, Clinical |
Product Type | Injection |
Grade Standard | Medicine Grade |
Packaging Type | Packet |
With our client oriented approaches, we are able to provide high-quality Victoza Liraglutide.
Precautions and Warnings:
- Initial Dose: 0.6 mg subcutaneously once a day for 1 week; this dose is intended to reduce gastrointestinal symptoms and is not an effective dose for glycemic control
- Maintenance dose: Inject 1.2 mg subcutaneously once a day; if acceptable glycemic control is not achieved, may increase to 1.8 mg subcutaneously once a day
* Maximum Dose: 1.8 mg once a day
Precautions and Warnings:
- Initial Dose: 0.6 mg subcutaneously once a day for 1 week; this dose is intended to reduce gastrointestinal symptoms and is not an effective dose for glycemic control
- Maintenance dose: Inject 1.2 mg subcutaneously once a day; if acceptable glycemic control is not achieved, may increase to 1.8 mg subcutaneously once a day
* Maximum Dose: 1.8 mg once a day
Exports To: United States Of America | Australia | United Kingdom | New Zealand | Canada
View Complete Details
Get Latest PriceRequest a quote
TrustSEAL Verified
Leading Supplier
Verified Exporter
100% Export Oriented Unit
View Mobile Number
78% Response RateContact Supplier
Product Details
Company Details
Product Specification
Brand | Victoza |
Usage/Application | Hospital, Personal, Clinical |
Product Type | Injection |
Grade Standard | Medicine Grade |
Packaging Type | Packet |
Medicine Type | Allopathic |
Minimum Order Quantity | 1 Piece |
Product Description
With our client oriented approaches, we are able to provide high-quality Victoza Liraglutide.
Precautions and Warnings:
Precautions and Warnings:
- Initial Dose: 0.6 mg subcutaneously once a day for 1 week; this dose is intended to reduce gastrointestinal symptoms and is not an effective dose for glycemic control
- Maintenance dose: Inject 1.2 mg subcutaneously once a day; if acceptable glycemic control is not achieved, may increase to 1.8 mg subcutaneously once a day
- Maximum Dose: 1.8 mg once a day
Interested in this product?Get Latest Price from the seller
Contact Seller
About the Company
Year of Establishment1982
Legal Status of FirmIndividual - Proprietor
Nature of Business100% Export Oriented Unit
Number of Employees51 To 100 People
Annual TurnoverRs. 5 - 10 Crore
IndiaMART Member SinceMar 2015
GST27ATQPP1847D1ZE
Import Export Code (IEC)ATQPP*****
Exports to United States Of America | Australia | United Kingdom | New Zealand | Canada
Established in the year 1982, Welcome Healthcare is a prominent Exporter , Wholesaler, Retailer and Trader of Wholesaler, Exporter and Trader of Pharmaceutical Injection, Eye Drops, Cancer Medicines, Anti Ageing Tablets,Anti Diabetic Medicines,Blood Pressure Medicines,Insulin, Hepatitis Medicine,Paon Killers,ED Medicines,Anti Anxiety Tablets and much more. medicinal products. We work with the support of our diligent and well-trained professionals who help us to provide our reliable products for various healthcare requirements. We work in a vast marketing network and maintain huge distribution network. Our products are sourced from authentic vendors and are supplied to several regions of the nation at the market leading prices. We deal in all Branded,Genric Companies.
Seller Contact Details
Dipesh P Chhajed
A9 Shriram Ind Estate 13 G.d Ambekar Road Wadala Mmbai 400031, Wadala Mumbai - 400031, Maharashtra, India
Get DirectionsView Mobile No.
Send SMS
Send Email